Research line IV: Personalized treatment
rapid optimization of optimal combination therapies, as desribed in
research line 3, presents an open door for precision medicine.
Using the FSC technology (Nowak-Sliwinska et al Nature Protocols, 2016)
on cell preparations from fresh tumor tissues optimal drug combinations
can be defined in a personalized way.